News | May 11, 2023
FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Subscribe To Our Newsletter & Stay Updated
